Lynne brings over 34 years of clinical research experience to SV Health Investors and has worked exclusively in Neurology for 22 years.
Lynne joined the SV as a Venture Partner in the Dementia Discovery Fund team after being Vice President and Global Head, Medical Strategy, Neurology at IQVIA. In her 22 years at IQVIA, Lynne worked exclusively in neurology and managed global development programs both from the operational perspective as a program director and also from the design perspective – working with clients to develop evidence-based strategies for the most efficient conduct of clinical development plans. She provided consultancy advice in Alzheimer’s disease (AD), Parkinson’s disease, pain indications, multiple sclerosis, acute care including TBI and stroke, migraine and epilepsy and a range of neuro-orphan indications.
Lynne sits on many advisory boards, with particular interest in neurocognitive assessment and design of appropriate studies to assess AD & neurocognitive dysfunction and is a member of many steering and / or executive committees. Lynne is a current member of the NIA-NIH task force for recruitment into AD trials and development of the US National Framework and is co-chair of the DAVOS (DAC) taskforce for expediting clinical AD trials, sponsored by WEF & CEOi. She is also a member of the G7 & G20 World Dementia Councils.
Outside of SV, Lynne enjoys skiing, tennis, keeping fit, gardening, traveling and gin!
PhD in Oncology and Cancer Biology from Birmingham University, PMP certified